2011
DOI: 10.1038/nchembio.585
|View full text |Cite|
|
Sign up to set email alerts
|

A biosensor generated via high-throughput screening quantifies cell edge Src dynamics

Abstract: Fluorescent biosensors for living cells currently require laborious optimization and a unique design for each target. They are limited by the availability of naturally occurring ligands with appropriate target specificity. Here we describe a biosensor based on an engineered fibronectin monobody scaffold that can be tailored to bind different targets via high throughput screening. This Src family kinase (SFK) biosensor was made by derivatizing a monobody specific for activated SFK with a bright dye whose fluore… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
91
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(93 citation statements)
references
References 51 publications
(91 reference statements)
2
91
0
Order By: Relevance
“…As described previously, biosensor concentrations were adjusted to report Cdc42 activity while minimizing perturbation of normal Cdc42 signaling. 5,2729 Consistent with earlier studies, Cdc42 was locally activated in protrusions. A control biosensor with point mutations known to reduce the CRIB domain’s affinity for active Cdc42 (mutant CRIB199 , H246D and H249D) 4,30 reduced the level of Cdc42 activation seen in the cells (Figures 3 and S5).…”
Section: Resultssupporting
confidence: 90%
“…As described previously, biosensor concentrations were adjusted to report Cdc42 activity while minimizing perturbation of normal Cdc42 signaling. 5,2729 Consistent with earlier studies, Cdc42 was locally activated in protrusions. A control biosensor with point mutations known to reduce the CRIB domain’s affinity for active Cdc42 (mutant CRIB199 , H246D and H249D) 4,30 reduced the level of Cdc42 activation seen in the cells (Figures 3 and S5).…”
Section: Resultssupporting
confidence: 90%
“…In combination with recent progress in cell-type-specific DNA delivery strategies (41), intrabodies perturbing specifically PTMs may become a valuable tool in signaling research or human and animal health. Furthermore, the uniformity and stability of the DARPin scaffold may greatly simplify the construction and optimization of fluorescent biosensors for living cells based on resonance energy transfer or attachment of environmentally sensitive dyes (42).…”
Section: Discussionmentioning
confidence: 99%
“…Thus, there has been a great deal of recent interest in tapping the potential of recombinant affinity reagents for characterizing the human proteome [1][2][3][4][5], and the early comparisons to traditional antibodies are promising [6,7]. Furthermore, it takes less time to identify a recombinant affinity reagent to a target than to generate a rabbit polyclonal or mouse monoclonal antibody [8], and one can do some experiments that are impossible with traditional antibodies, such as evolve higher affinities [9,10], express inside cells and perturb targets [11,12], mislocalize targets in embryos [13], create biosensors [14], and incorporate unnatural amino acids for chemical derivatization [15], which allows new labeling, capturing and immobilization approaches.…”
Section: Introductionmentioning
confidence: 99%